STAAR Surgical Announces Fourth Quarter And Full Year 2005 Earnings Release Date And Conference Call

MONROVIA, Calif., Feb. 17 /PRNewswire-FirstCall/ -- STAAR Surgical Company today announced that it will release financial results for the fourth quarter and full year ended December 30, 2005, on Thursday, March 2, 2006, after the market close. The Company will host a conference call and webcast on Thursday, March 2, 2006, at 5:00 p.m. Eastern Time to discuss the Company’s fourth quarter and full year results and current corporate developments. The dial-in number for the conference call is 800-257-1836 for domestic participants and 303-262-2140 for international participants.

A taped replay of the conference call will also be available beginning approximately one hour after the call’s conclusion and will be available for seven days. This replay can be accessed by dialing 800-405-2236 for domestic callers and 303-590-3000 for international callers, both using passcode 11054531#. To access the live webcast of the call, go to STAAR Surgical’s website at www.staar.com. An archived webcast will also be available at www.staar.com

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR’s products are used by ophthalmic surgeons and include the VISIAN ICL as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. STAAR’s ICL is approved by the FDA for use in treating myopia, has received CE Marking and is approved for sale in 42 countries. More than 50,000 ICLs have been sold worldwide. More information is available at www.staar.com.

Contacts: Investors Media EVC Group EVC Group Douglas Sherk, 415-896-6820 Steve DiMattia Jennifer Beugelmans, 415-896-6820 646-277-8706

STAAR Surgical Company

CONTACT: Investors: Douglas Sherk or Jennifer Beugelmans, both+1-415-896-6820, or Media: Steve DiMattia, +1-646-277-8706, all of EVCGroup, for STAAR Surgical Company

MORE ON THIS TOPIC